Eli Lilly & Co. (NYSE:LLY)

Sell-Off or Not, 7 Blue Chips and Industry Leaders Analysts Want You to Buy Now

The week of March 22, 2019, ended on a very sour note with the Dow Jones industrials selling off on Friday alone by a sharp 460 points and the S&P ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Allergan, Costco, Cree, Dollar Tree, Eli Lilly, FedEx, Mylan, NextEra, Peabody, Teva, Yum Brands and More

Stocks were indicated to open marginally higher on Wednesday ahead of the FOMC decision on interest rates. With the market having recouped so much ground in 2019, investors need to ...
Read Full Story »

Top Analyst Upgrades and Downgrades: AEP, Apple, Boeing, Coca-Cola, Eli Lilly, RingCentral, Tellurian, Tesla, Vonage and More

Stocks were mixed and looking for direction on Tuesday after Monday's rally. Despite last week's selling pressure, it is important to keep in mind that the Dow Jones industrials had ...
Read Full Story »

Big Pharma Short Interest Backs Off, With One Huge Exception

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

The 6 Most Shorted NYSE Stocks

After the strong start to the year, the momentum in the big U.S. stock indexes began to slow late in February. Trade concerns and fears of inflation or another recession ...
Read Full Story »

Major Pharma Sees Tremendous Rise in Short Interest

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Major Pharma Scares Off Short Sellers

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Alphabet, Disney, GM, Twitter and More Major Earnings Coming This Week

Earnings season continues and more major companies are gearing up to report and affect the direction of the broad markets. Last week 12 Dow Jones industrial average components and other ...
Read Full Story »

Short Interest Spikes in a Couple Major Pharma Stocks

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Major Pharma Sees Fading Short Interest

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Are Loxo Shareholders Getting Enough in the Buyout?

Loxo Oncology Inc. (NASDAQ: LOXO) shares made a massive gain on Monday after it was announced that the firm would be acquired by Eli Lilly and Co. (NYSE: LLY). The ...
Read Full Story »

Short Sellers Hike Bets in Major Pharma Stocks

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Top Analyst Upgrades and Downgrades: Altbaba, AutoDesk, AutoZone, CBS, Eli Lilly, Lululemon, Michael’s, Target and More

The futures traded down big on Thursday morning but were off the lows as investors digest the massive record Wednesday rally on Wall Street. Incredible retail numbers were posted on ...
Read Full Story »

Eli Lilly Scores Solid Results in Psoriatic Arthritis Study

Eli Lilly and Co. (NYSE: LLY) has announced positive results from its late-stage active psoriatic arthritis (PsA) study. This trial is the first completed large head-to-head superiority study in active ...
Read Full Story »

Eli Lilly Receives Crucial FDA Update on Lupus Study

The U.S. Food and Drug Administration (FDA) has granted a Fast Track designation to Eli Lilly and Co.'s (NYSE: LLY) baricitinib, which is being studied for the treatment of systemic lupus ...
Read Full Story »